Simon D. Message
Impact in
- Emergency Medical Services top 0.2%
- Pediatric health and respiratory diseases
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Physiology 18
- Asthma and respiratory diseases 18
- Immunology 12
- IL-33, ST2, and ILC Pathways 9
- Immune Cell Function and Interaction 8
- Immune Response and Inflammation 2
- Co-authors
- Sebastian Lennox Johnston (28 shared papers)Onn Min Kon (16 shared papers)Luminita Aurelia Stanciu (17 shared papers)Tatiana Kebadze (16 shared papers)Patrick Mallia (18 shared papers)ALBERTO PAPI (14 shared papers)Vasile Laza‐Stanca (11 shared papers)Marco Contoli (10 shared papers)
- Journals
- The Lancet (6 papers)American Journal of Respiratory and Critical Care Medicine (3 papers)Journal of Allergy and Clinical Immunology (3 papers)Allergy (2 papers)European Respiratory Journal (2 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Simon D. Message
43 papers receiving 5.6k citations
Simon D. Message's Hit Papers
Peers
Comparison fields: 5 of 124
- Emergency Medical Services 656
- Infectious Diseases 1.2k
- Physiology 1.7k
- Immunology 1.3k
- Pulmonary and Respiratory Medicine 1.5k
Countries citing papers authored by Simon D. Message
This map shows the geographic impact of Simon D. Message's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon D. Message with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon D. Message more than expected).
Fields of papers citing papers by Simon D. Message
This network shows the impact of papers produced by Simon D. Message. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon D. Message. The network helps show where Simon D. Message may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon D. Message, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of deficient type III interferon-λ production in asthma exacerbations Hit paper breakdown → | 2006 | 870 |
| 2 | Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease Hit paper breakdown → | 2001 | 853 |
| 3 | 2008 | 417 | |
| 4 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 5 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 6 | 2010 | 335 | |
| 7 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 8 | 2010 | 273 | |
| 9 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 10 | 2012 | 223 | |
| 11 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 12 | 2020 | 134 | |
| 13 | 2003 | 131 | |
| 14 | 2010 | 97 | |
| 15 | 2006 | 87 | |
| 16 | 2006 | 85 | |
| 17 | 2023 | 83 | |
| 18 | 2014 | 82 | |
| 19 | 2001 | 78 | |
| 20 | 2018 | 77 |
About Simon D. Message
Simon D. Message is a scholar working on Physiology, Immunology, Emergency Medical Services, Epidemiology and Infectious Diseases, having authored 44 papers that have together received 5.9k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (18 papers), IL-33, ST2, and ILC Pathways (9 papers), Immune Cell Function and Interaction (8 papers), Respiratory viral infections research (8 papers), Pediatric health and respiratory diseases (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Immune Response and Inflammation (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). The work is most often cited by research in Emergency Medical Services (656 citations), Infectious Diseases (1.2k citations), Physiology (1.7k citations), Immunology (1.3k citations) and Pulmonary and Respiratory Medicine (1.5k citations). Simon D. Message has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Sebastian Lennox Johnston, Onn Min Kon, Luminita Aurelia Stanciu, Tatiana Kebadze, Patrick Mallia, ALBERTO PAPI, Vasile Laza‐Stanca, Marco Contoli, Michael R. Edwards and Hayley L. Parker. Their work appears in journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology, Allergy and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.